EFFICACY AND SAFETY OF TREATMENT WITH BEVACIZUMAB (BEV) plus CHEMOTHERAPY (CT) BEYOND FIRST PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) PREVIOUSLY TREATED WITH BEV plus CT: AGE SUBGROUP ANALYSIS FROM A RANDOMISED PHASE III INTERGROUP STUDY (ML18147)

O. Bouche; C. Steffens; T. Andre; J. Bennouna; J. Sastre; P. Osterlund; R. von Moos; I. Reyes-Rivera; M. A. Sersch; D. Arnold

EFFICACY AND SAFETY OF TREATMENT WITH BEVACIZUMAB (BEV) plus CHEMOTHERAPY (CT) BEYOND FIRST PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) PREVIOUSLY TREATED WITH BEV plus CT: AGE SUBGROUP ANALYSIS FROM A RANDOMISED PHASE III INTERGROUP STUDY (ML18147)

O. Bouche, C. Steffens, T. Andre, J. Bennouna, J. Sastre, P. Osterlund, R. von Moos, I. Reyes-Rivera, M. A. Sersch, D. Arnold

Research output: Contribution to journal › Article › Scientific

Original language	English
Journal	Annals of Oncology
Volume	23
Pages (from-to)	190-191
Number of pages	2
ISSN	0923-7534
Publication status	Published - Sept 2012
MoE publication type	B1 Journal article

Fields of Science

3122 Cancers

Cite this

Bouche, O., Steffens, C., Andre, T., Bennouna, J., Sastre, J., Osterlund, P., von Moos, R., Reyes-Rivera, I., Sersch, M. A., & Arnold, D. (2012). EFFICACY AND SAFETY OF TREATMENT WITH BEVACIZUMAB (BEV) plus CHEMOTHERAPY (CT) BEYOND FIRST PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) PREVIOUSLY TREATED WITH BEV plus CT: AGE SUBGROUP ANALYSIS FROM A RANDOMISED PHASE III INTERGROUP STUDY (ML18147). Annals of Oncology, 23, 190-191.

Bouche, O. ; Steffens, C. ; Andre, T. et al. / EFFICACY AND SAFETY OF TREATMENT WITH BEVACIZUMAB (BEV) plus CHEMOTHERAPY (CT) BEYOND FIRST PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) PREVIOUSLY TREATED WITH BEV plus CT: AGE SUBGROUP ANALYSIS FROM A RANDOMISED PHASE III INTERGROUP STUDY (ML18147). In: Annals of Oncology. 2012 ; Vol. 23. pp. 190-191.

@article{43303964e60f4357b1e1e4db847e75fe,

title = "EFFICACY AND SAFETY OF TREATMENT WITH BEVACIZUMAB (BEV) plus CHEMOTHERAPY (CT) BEYOND FIRST PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) PREVIOUSLY TREATED WITH BEV plus CT: AGE SUBGROUP ANALYSIS FROM A RANDOMISED PHASE III INTERGROUP STUDY (ML18147)",

keywords = "3122 Cancers",

author = "O. Bouche and C. Steffens and T. Andre and J. Bennouna and J. Sastre and P. Osterlund and {von Moos}, R. and I. Reyes-Rivera and Sersch, {M. A.} and D. Arnold",

year = "2012",

month = sep,

language = "English",

volume = "23",

pages = "190--191",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd. ",

}

Bouche, O, Steffens, C, Andre, T, Bennouna, J, Sastre, J, Osterlund, P, von Moos, R, Reyes-Rivera, I, Sersch, MA & Arnold, D 2012, 'EFFICACY AND SAFETY OF TREATMENT WITH BEVACIZUMAB (BEV) plus CHEMOTHERAPY (CT) BEYOND FIRST PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) PREVIOUSLY TREATED WITH BEV plus CT: AGE SUBGROUP ANALYSIS FROM A RANDOMISED PHASE III INTERGROUP STUDY (ML18147)', Annals of Oncology, vol. 23, pp. 190-191.

EFFICACY AND SAFETY OF TREATMENT WITH BEVACIZUMAB (BEV) plus CHEMOTHERAPY (CT) BEYOND FIRST PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) PREVIOUSLY TREATED WITH BEV plus CT: AGE SUBGROUP ANALYSIS FROM A RANDOMISED PHASE III INTERGROUP STUDY (ML18147). / Bouche, O.; Steffens, C.; Andre, T. et al.
In: Annals of Oncology, Vol. 23, 09.2012, p. 190-191.

Research output: Contribution to journal › Article › Scientific

TY - JOUR

T1 - EFFICACY AND SAFETY OF TREATMENT WITH BEVACIZUMAB (BEV) plus CHEMOTHERAPY (CT) BEYOND FIRST PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) PREVIOUSLY TREATED WITH BEV plus CT: AGE SUBGROUP ANALYSIS FROM A RANDOMISED PHASE III INTERGROUP STUDY (ML18147)

AU - Bouche, O.

AU - Steffens, C.

AU - Andre, T.

AU - Bennouna, J.

AU - Sastre, J.

AU - Osterlund, P.

AU - von Moos, R.

AU - Reyes-Rivera, I.

AU - Sersch, M. A.

AU - Arnold, D.

PY - 2012/9

Y1 - 2012/9

KW - 3122 Cancers

M3 - Article

SN - 0923-7534

VL - 23

SP - 190

EP - 191

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Bouche O, Steffens C, Andre T, Bennouna J, Sastre J, Osterlund P et al. EFFICACY AND SAFETY OF TREATMENT WITH BEVACIZUMAB (BEV) plus CHEMOTHERAPY (CT) BEYOND FIRST PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) PREVIOUSLY TREATED WITH BEV plus CT: AGE SUBGROUP ANALYSIS FROM A RANDOMISED PHASE III INTERGROUP STUDY (ML18147). Annals of Oncology. 2012 Sept;23:190-191.